These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 21479128

  • 1. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development.
    Zhao C, Wu LS, Barner R.
    J Cancer; 2011 Feb 21; 2():94-106. PubMed ID: 21479128
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
    Bell KA, Kurman RJ.
    Am J Surg Pathol; 2000 Nov 21; 24(11):1465-79. PubMed ID: 11075848
    [Abstract] [Full Text] [Related]

  • 4. Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases.
    Snyder RR, Norris HJ, Tavassoli F.
    Am J Surg Pathol; 1988 Sep 21; 12(9):661-71. PubMed ID: 3414893
    [Abstract] [Full Text] [Related]

  • 5. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D, Murali R, Murray MP, Veras E, Park KJ, Soslow RA.
    Am J Surg Pathol; 2016 Mar 21; 40(3):302-12. PubMed ID: 26551621
    [Abstract] [Full Text] [Related]

  • 6. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma.
    Roth LM, Langley FA, Fox H, Wheeler JE, Czernobilsky B.
    Cancer; 1984 Mar 01; 53(5):1156-63. PubMed ID: 6692303
    [Abstract] [Full Text] [Related]

  • 7. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J, McCluggage WG.
    Am J Surg Pathol; 2015 Jul 01; 39(7):983-92. PubMed ID: 25723110
    [Abstract] [Full Text] [Related]

  • 8. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R, Kurman RJ, Logani S, Shih IeM.
    Am J Surg Pathol; 2007 Jul 01; 31(7):1007-12. PubMed ID: 17592266
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ.
    Am J Surg Pathol; 2002 Dec 01; 26(12):1529-41. PubMed ID: 12459620
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clear Cell Adenocarcinoma Arising from Adenofibroma in a Patient with Endometriosis of the Ovary.
    Cho I, Lim SC.
    J Pathol Transl Med; 2016 Mar 01; 50(2):155-9. PubMed ID: 26498012
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
    Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM.
    Int J Gynecol Pathol; 2012 Jul 01; 31(4):297-303. PubMed ID: 22653341
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics.
    Yamamoto S, Tsuda H, Yoshikawa T, Kudoh K, Kita T, Furuya K, Tamai S, Matsubara O.
    Am J Surg Pathol; 2007 Jul 01; 31(7):999-1006. PubMed ID: 17592265
    [Abstract] [Full Text] [Related]

  • 17. Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report.
    Vasilakaki T, Skafida E, Arkoumani E, Grammatoglou X, Firfiris N, Manoloudaki K.
    Eur J Gynaecol Oncol; 2012 Jul 01; 33(2):230-2. PubMed ID: 22611972
    [Abstract] [Full Text] [Related]

  • 18. Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.
    Yamamoto S, Tsuda H, Takano M, Kita T, Kudoh K, Furuya K, Tamai S, Matsubara O.
    Mod Pathol; 2008 Feb 01; 21(2):115-24. PubMed ID: 18084257
    [Abstract] [Full Text] [Related]

  • 19. Ovarian endometrioid adenofibromatous and cystadenofibromatous tumors: benign, proliferating, and malignant.
    Roth LM, Czernobilsky B, Langley FA.
    Cancer; 1981 Oct 15; 48(8):1838-45. PubMed ID: 7284979
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
    Nishio N, Kido A, Kataoka M, Kuwahara R, Nakao K, Kurata Y, Matsumura N, Mandai M, Togashi K.
    Eur J Radiol; 2018 Aug 15; 105():175-181. PubMed ID: 30017276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.